TLRY (Tilray Brands) Cash And Cash Equivalents : $205.2 Mil (As of Aug. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Tilray Brands Cash And Cash Equivalents?

Tilray Brands's quarterly cash and cash equivalents increased from Feb. 2024 ($146.25 Mil) to May. 2024 ($228.34 Mil) but then stayed the same from May. 2024 ($228.34 Mil) to Aug. 2024 ($205.19 Mil).

Tilray Brands's annual cash and cash equivalents declined from May. 2022 ($415.91 Mil) to May. 2023 ($206.63 Mil) but then increased from May. 2023 ($206.63 Mil) to May. 2024 ($228.34 Mil).

Tilray Brands Cash And Cash Equivalents Historical Data

The historical data trend for Tilray Brands's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tilray Brands Cash And Cash Equivalents Chart

Tilray Brands Annual Data

Trend

May15

May16

May17

May18

May19

May20

May21

May22

May23

May24

Cash And Cash Equivalents

Get a 7-Day Free Trial

360.65

488.47

415.91

206.63

228.34

Tilray Brands Quarterly Data
	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24
Cash And Cash Equivalents	Get a 7-Day Free Trial															177.52	143.37	146.25	228.34	205.19

Tilray Brands Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Tilray Brands (NAS:TLRY) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Tilray Brands Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Tilray Brands's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Tilray Brands Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tilray Brands Inc (NAS:TLRY) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

2HQ:Germany TLRY:Canada TLRY:Austria

Address

265 Talbot Street West, Leamington, ON, CAN, N8H 5L4

Website

https://www.tilray.com

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol.

Executives

Carl A Merton	officer: Chief Financial Officer	C/O TILRAY, INC., 745 FIFTH AVENUE, SUITE 1602, NEW YORK NY 10151
Denise M Faltischek	officer: Chief Strategy Officer	C/O THE HAIN CELESTIAL GROUP, INC., 1111 MARCUS AVENUE, LAKE SUCCESS NY 11042
Mitchell Gendel	officer: Global General Counsel	EMERALD HOLDING, INC., 100 BROADWAY, 14TH FLOOR, NEW YORK NY 10005
Irwin D Simon	director, officer: President & CEO	C/O THE HAIN CELESTIAL GROUP INC., 1111 MARCUS AVENUE, LAKE SUCCESS NY 11042
Brendan Kennedy	director	1920 EASTLAKE AVENUE E., SEATTLE WA 98105
James R. Meiers	officer: Head of Canada	C/O TILRAY, INC., 655 MADISON AVENUE, 19TH FLOOR, NEW YORK NY 10065
David G. Hopkinson	director	C/O TILRAY, INC., 655 MADISON AVENUE, 19TH FLOOR, NEW YORK NY 10065
Thomas P. Looney	director	C/O TILRAY, INC., 655 MADISON AVENUE, 19TH FLOOR, NEW YORK NY 10065
Johann Michael Herhalt	director	C/O TILRAY, INC., 655 MADISON AVENUE, 19TH FLOOR, NEW YORK NY 10065
Jodi L. Butts	director	C/O TILRAY, INC., 655 MADISON AVENUE, 19TH FLOOR, NEW YORK NY 10065
David F Clanachan	director	TIM HORTONS INC., 874 SINCLAIR ROAD, OAKVILLE A6 L6K 2Y1
Renah Persofsky	director	55 PRINCE ARTHUR AVENUE, #604, TORONTO A6 M5R 1B3
Jon Edward Levin	officer: Chief Operating Officer	2701 EASTLAKE AVE E, 3RD FLOOR, SEATTLE WA 98102
Michael C. Kruteck	officer: Chief Financial Officer	2701 EASTLAKE AVE E, 3RD FLOOR, SEATTLE WA 98102
Rebekah Dopp	director	444 LENOX AVENUE, SOUTH ORANGE NJ 07079